Skin Cancer Diagnostics Market Report 2026

Skin Cancer Diagnostics Market Overview

• Skin Cancer Diagnostics market size has reached to $3.38 billion in 2025 • Expected to grow to $5.09 billion in 2030 at a compound annual growth rate (CAGR) of 8.6% • Growth Driver: Rising Melanoma Cases Fueling Growth In Skin Cancer Diagnostics Market • Market Trend: AI Integration For Unprecedented Accuracy Revolutionizes Skin Cancer Diagnostics • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Skin Cancer Diagnostics Market?

Skin cancer diagnostics refers to the processes and methods healthcare professionals use to identify and determine the presence of skin cancer in individuals. These diagnostics typically involve a combination of clinical examination, imaging techniques, and laboratory tests to evaluate suspicious skin lesions and assess the extent and characteristics of the cancer. The main types of skin cancer diagnostics are basal cell carcinoma, squamous cell carcinoma, malignant melanoma, and others. Basal Cell Carcinoma is the most common form of skin cancer that arises from the basal cells of the skin's lower epidermis. The various types include diagnosis, and therapeutics, that are widely applied in hospitals, clinics, laboratories, and others.

What Is The Skin Cancer Diagnostics Market Growth Forecast?

The skin cancer diagnostics market size is expected to see strong growth in the next few years. It will grow to $5.09 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to adoption of AI and imaging diagnostics, growth in non-invasive molecular techniques, expansion of teledermatology, increasing early detection initiatives, integration with personalized treatment plans. Major trends in the forecast period include rise in non-invasive diagnostic techniques, integration with AI-based skin imaging, adoption of molecular diagnostics, growth in early detection programs, expansion in teledermatology platforms.

Global Skin Cancer Diagnostics Market Segmentation

1) By Cancer Type: Basal Cell Carcinoma, Squamous Cell Carcinoma, Malignant Melanoma, Other Cancer Types 2) By Type: Diagnosis, Detection Solutions 3) By Application: Hospital, Clinic, Laboratory, Other Applications Subsegments: 1) By Basal Cell Carcinoma: Diagnostic imaging Techniques, Biopsy Procedures, Molecular Diagnostic Tests 2) By Squamous Cell Carcinoma: Diagnostic imaging Techniques, Biopsy Procedures, Molecular Diagnostic Tests 3) By Malignant Melanoma: Diagnostic Imaging Techniques, Biopsy Procedures, Molecular Diagnostic Tests 4) By Other Cancer Types: Non-Melanoma Skin Cancers, Dermatofibrosarcoma Protuberans, Merkel Cell Carcinoma

What Is The Driver Of The Skin Cancer Diagnostics Market?

The increase in the incidence of melanoma is expected to propel the growth of the skin cancer diagnostics market going forward. Melanoma is a type of skin cancer that develops in the cells that produce melanin, the pigment responsible for skin color, hair, and eyes. Skin cancer diagnostics are crucial in identifying and characterizing skin lesions, aiding in early detection, accurate diagnosis, and effective treatment planning for skin cancer. For instance, in 2023, according to the report published by the American Cancer Society Inc., a US-based nationwide voluntary health organization dedicated to eliminating cancer, the number of male individuals suffering from melanoma in the United States increased from 57,180 in 2022 to 58,120 in 2023. Furthermore, in March 2023, according to the American Society of Clinical Oncology, a US-based professional organization representing all oncology physicians, melanoma accounts for around 1% of all skin cancers diagnosed in the United States. Yet, it is responsible for most skin cancer mortality. Melanoma is expected to kill 7,990 people in the United States in 2023 (5,420 males and 2,570 women). Therefore, an increase in incidences of melanoma is driving the growth of the skin cancer diagnostics industry.

Key Players In The Global Skin Cancer Diagnostics Market

Major companies operating in the skin cancer diagnostics market are Pfizer Inc., F. Hoffmann-La Roche Limited, Merck & Co., Novartis AG, Bristol-Myers Squibb Company, Canon Medical Systems Corporation, Amgen Inc., GE Healthcare, Agilent Technologies Inc., bioMerieux SA, Teva Pharmaceutical Industries, Bruker Corp, Genentech, Castle Biosciences, DermTech Inc., SkylineDx BV, DermLite LLC, Biolitec Ag, Alma Lasers, AMLo Biosciences Limited, National Cancer Institute, Almirall

Global Skin Cancer Diagnostics Market Trends and Insights

Major companies operating in the skin cancer diagnostics market are focusing on advanced services such as AI-powered pop-up clinics to gain a competitive advantage. An AI-powered pop-up clinic is a temporary healthcare facility equipped with artificial intelligence technologies to provide efficient and technologically advanced medical services in a specific location or for a particular purpose. For instance, in January 2023, Skin Check Champions, an Australia-based health charity organization dedicated to promoting skin health awareness, partnered with The University of South Australia, an Australia-based academic institution, and The Hospital Research Foundation, an Australia-based non-profit organization, to introduce an AI-powered pop-up clinic focused on skin cancer diagnosis. Managed by nurses, the clinic captures high-quality images of lesions from patients, subsequently subjecting them to AI algorithms for a preliminary diagnosis of potential malignancy. The findings are further confirmed by local general practitioners (GPs).

What Are Latest Mergers And Acquisitions In The Skin Cancer Diagnostics Market?

In March 2025, Gestalt Diagnostics, a US-based digital pathology solutions provider, formed a collaboration with Primaa, to advance skin cancer detection through AI-powered diagnostic tools. The partnership aims to integrate Primaa’s deep-learning dermatopathology algorithms with Gestalt’s digital pathology platform to enhance diagnostic accuracy, accelerate clinical workflows, and support early identification of melanoma and other skin cancers, thereby improving patient outcomes and supporting the scalability of AI adoption in clinical dermatopathology. Primaa is a France-based AI-driven dermatopathology company specializes in artificial intelligence solutions for dermatopathology and precision skin cancer diagnostics.

Regional Outlook

North America was the largest region in the skin cancer diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Skin Cancer Diagnostics Market?

The skin cancer diagnostics market consists of revenues earned by entities by providing skin cancer diagnostics services such as diagnostic tests, visual inspection, dermoscopy, biopsy, imaging techniques (ultrasound, CT scan, MRI), laboratory tests (immunohistochemistry, molecular testing, genetic analysis). The market value includes the value of related goods sold by the service provider or included within the service offering. The skin cancer diagnostics market also includes sales of dermatoscopes, biopsy tools, imaging equipment (ultrasound, CT scanners, MRI machines), molecular testing kits, immunohistochemistry (IHC) kits, and laboratory analysis software. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Skin Cancer Diagnostics Market Report 2026?

The skin cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the skin cancer diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.